1. Home
  2. RVLV vs IMTX Comparison

RVLV vs IMTX Comparison

Compare RVLV & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revolve Group Inc.

RVLV

Revolve Group Inc.

SELL

Current Price

$22.79

Market Cap

1.5B

ML Signal

SELL

IMTX

Immatics N.V.

HOLD

Current Price

$6.70

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVLV
IMTX
Founded
2003
N/A
Country
United States
Germany
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
RVLV
IMTX
Price
$22.79
$6.70
Analyst Decision
Buy
Strong Buy
Analyst Count
15
9
Target Price
★ $30.85
$17.26
AVG Volume (30 Days)
612.7K
★ 855.3K
Earning Date
11-03-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 24.64
N/A
EPS
★ 0.46
N/A
Revenue
★ $1,225,682,000.00
N/A
Revenue This Year
$13.31
N/A
Revenue Next Year
$9.03
N/A
P/E Ratio
$50.48
★ N/A
Revenue Growth
★ 8.48
N/A
52 Week Low
$17.35
$6.73
52 Week High
$31.68
$12.41

Technical Indicators

Market Signals
Indicator
RVLV
IMTX
Relative Strength Index (RSI) 61.31 28.56
Support Level $22.47 N/A
Resistance Level $26.97 $10.08
Average True Range (ATR) 0.70 0.42
MACD 0.25 -0.08
Stochastic Oscillator 72.84 3.19

Price Performance

Historical Comparison
RVLV
IMTX

About RVLV Revolve Group Inc.

Revolve Group Inc is an emerging e-commerce retailer, selling women's dresses, handbags, shoes, beauty products, and incidentals across its marketplace properties, Revolve and FWRD. The platform is built to suit the "next-generation customer," emphasizing mobile commerce, influencer marketing, and occupying an aspirational but attainable luxury niche. With $1.1 billion in 2024 net sales, the firm sits just outside the top 30 apparel retailers (by sales) in the U.S, but has consistently generated robust top-line growth as the industry continues to favor digital channels. Revolve generates approximately 18% of sales from private-label offerings, while focusing on building an inventory of distinctive products from emerging fashion brands with less than $10 million in annual sales.

About IMTX Immatics N.V.

Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Share on Social Networks: